Tag: metastasis

Are you a prostate cancer (PCa) patient on Active Surveillance? If so, do you ever worry if there’s a chance your cancer will progress and start to spread (metastasize)? A new study suggests that your best investment against metastasis may be a home treadmill or exercise bike so you can get a vigorous aerobic workout keep reading

A PSMA PET/CT scan (or simply PSMA PET) like the one described below that incorporates the radioisotope Gallium-68, is the most sensitive method to detect metastatic prostate cancer (mPCa). PSMA PET has thus quickly gained wide use, including evaluating how well a patient’s mPCa is responding to therapy... keep reading

An exciting new imaging modality called PSMA PET/CT has entered the global prostate cancer diagnosis scene. When a short-lived positron emitting isotope called Gallium 68 is bonded to a molecule that is attractive to a specific protein found abundantly on the surface of prostate cancer (PCa) cells, the cells “light up” on PET/CT scans. keep reading

When it comes to diagnosing localized prostate cancer (PCa), there’s the old world and the new world. Localized PCa means the disease is still contained in the prostate gland at the time of treatment. This knowledge is a crucial key to wise treatment decisions, especially radical treatments aimed at removing or destroying the entire gland. keep reading

When something could save lives, having an abundance of it on hand is a good thing. On the other hand, if there’s a scarcity of it, it won’t be readily available when it’s needed—and many lives will be put at risk. This is true for a prostate cancer (PCa) imaging agent called Gallium-68 (68Ga or keep reading

There’s an exciting new development in treating metastatic prostate cancer (PCa) that no longer responds to hormone therapy. Such cancer is clinically called metastatic castration-resistant prostate cancer, or mCRPC. There is currently no cure when PCa reaches this stage, but new drugs and immunotherapies can prolong life. Researchers are exploring and testing therapies that destroy keep reading

Wouldn’t it be great if a patient with metastatic cancer could simply have the primary tumor treated—then all the others would miraculously start to disappear? Well, we don’t yet have the such clinical wizardry, but it looks the body itself has such a capacity! It’s called the abscopal effect (pronounced ab-SCOPE-ul). Studies are now revealing keep reading

“Lutetium-177 (¹⁷⁷Lu)-PSMA-617 is a radioligand therapy that delivers beta-particle radiation to PSMA-expressing cells and the surrounding microenvironment.” Since we posted the 2017 blog below, research into Lutetium-177 has been ongoing. The opening quote for this update comes from a September, 2021 published clinical study by Sartor et al... keep reading

Over 1,200,000 men around the globe are diagnosed with prostate cancer (PCa) every year. They don’t all have the same disease, however. There are numerous cell lines with varying characteristics: “The disease is very heterogeneous in terms of grade, genetics, ploidy, and oncogene/tumor suppressor gene expression, and its biological, hormonal, and molecular characteristics are extremely keep reading

At the time of this writing, it’s been over a year since SARS-CoV-2, the virus that causes COVID-19, was confirmed in the U.S. Scientists around the world scrambled to unravel the mysteries of this coronavirus while millions of people around the globe have died. At this time, there are a reported 114 million active cases keep reading